Herbalife (HLF) surged 5.57% in pre-market trading, reflecting strong investor optimism following positive analyst actions.
The rally was fueled by Argus Research upgrading Herbalife to Buy from Hold, citing the company's Q3 earnings beat. Additionally, Mizuho raised its target price for Herbalife to $11 from $10, further bolstering confidence in the stock.